CSIMarket


Yubo International Biotech Limited  (MAGAA)
Other Ticker:  
 

Yubo International Biotech Limited

MAGAA's Fundamental analysis








Yubo International Biotech Limited's sales fell by -85.17 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 3289

Medical Equipment & Supplies industry recorded growth of revenues by 1.98 %

Yubo International Biotech Limited net loss deacreased by in III. Quarter 2022 year on year, Yubo International Biotech Limited net loss increased by -29.26 % in III. Quarter 2022 year on year,

More on MAGAA's Growth


Yubo International Biotech Limited
reported net loss of -2 millions in the past twelve months.

Company is currently trading with Price to Cash flow multiple of 5140.95 in trailing twelve-month period.
Company